Sight Sciences Inc (SGHT)
Healthcare
Medical Devices
5.30 $
+0.0%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Sight Sciences Inc (SGHT)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 64.7% of the shares are freely tradable; institutional investors hold 54.0%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
54.0%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
20.4%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
64.7%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
2.0%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
54Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Long Focus Capital Management, LLC | 6.61 | 3,594,100 | +9.2 | 03/31/2026 |
| BlackRock Inc | 5.21 | 2,831,932 | +5.9 | 03/31/2026 |
| Pathstone Holdings LLC | 4.41 | 2,397,332 | +233.7 | 03/31/2026 |
| Vanguard Group Inc | 3.58 | 1,948,647 | +2.2 | 12/31/2025 |
| Americana Partners, LLC | 3.09 | 1,679,017 | +21.8 | 03/31/2026 |
| Vanguard Capital Management, LLC | 2.67 | 1,452,690 | +0.0 | 03/31/2026 |
| B Group, Inc | 1.78 | 970,000 | +5.4 | 03/31/2026 |
| Geode Capital Management, LLC | 1.68 | 915,444 | +3.9 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 1.94 | 1,053,900 | +0.0 | 04/30/2026 |
| iShares Russell 2000 ETF | 1.82 | 990,134 | +0.9 | 05/29/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.